Category: General News
Search News
International study reveals four distinct types of oesophageal cancer
23rd October 2024
New research reveals that the most common type of oesophageal cancer, oesophageal squamous cell carcinoma (ESCC), is composed of four distinct subtypes—each of which may benefit from different treatment approaches.
Read more
Scientists uncover promising leukaemia treatment targeting fat metabolism
17th October 2024
Researchers at Barts Cancer Institute reveal promising acute myeloid leukaemia treatment targeting fat metabolism, addressing the urgent need for better therapies.
Read more
Helping cancer patient advocates find their voice
10th October 2024
We recently welcomed a group of 16 cancer patient advocates into our labs for the 11th edition of our VOICE science for advocates course, co-run with the charity Independent Cancer Patients’ Voice.
Read more
BCI part of new UK-wide cancer immunotherapy initiative
7th October 2024
Researchers from Barts Cancer Institute, Queen Mary University of London are part of a nationwide team of universities, hospitals and industry collaborating on a new platform to understand immunotherapy response and side effects in cancer.
Read more
Groundbreaking trials reveal improved survival for two hard-to-treat cancers
16th September 2024
Prof Tom Powles and Prof Peter Schmid announced practice-changing results at ESMO 2024
Read more
Video: Engineering a Tumour on a Chip
29th August 2024
Meet Dr Joash Joy, a postdoctoral researcher working on engineering artificial tumours to explore how cancer therapies can be made more effective.
Read more